Cargando…

Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression

Increased overall survival for patients with glioma brain tumours is associated with mutations in the metabolic regulator isocitrate dehydrogenase 1 (IDH1). Gliomas develop within a mechanically challenged microenvironment that is characterized by a dense extracellular matrix (ECM) that compromises...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miroshnikova, Yekaterina A., Mouw, Janna K., Barnes, J. Matthew, Pickup, Michael W., Lakins, Johnathan N., Kim, Youngmi, Lobo, Khadjia, Persson, Anders I., Reis, Gerald F., McKnight, Tracy R., Holland, Eric C., Phillips, Joanna J., Weaver, Valerie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361403/ https://www.ncbi.nlm.nih.gov/pubmed/27820599 http://dx.doi.org/10.1038/ncb3429

Ejemplares similares

Feeling Stress: The Mechanics of Cancer Progression and Aggression
por: Northcott, Josette M., et al.
Publicado: (2018)

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression
por: Laklai, Hanane, et al.
Publicado: (2016)

LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect
por: Xiang, Shaoxun, et al.
Publicado: (2018)

Oligosarcomas, IDH-mutant are distinct and aggressive
por: Suwala, Abigail K., et al.
Publicado: (2021)

Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
por: Mouw, Janna K, et al.
Publicado: (2014)

Mutant IDH1 regulates the tumor-associated immune system in gliomas
por: Amankulor, Nduka M., et al.
Publicado: (2017)

α5β1-Integrin promotes tension-dependent mammary epithelial cell invasion by engaging the fibronectin synergy site
por: Miroshnikova, Y. A., et al.
Publicado: (2017)

IDH1 Mutation Induces HIF-1α and Confers Angiogenic Properties in Chondrosarcoma JJ012 Cells
por: Hu, Xiaoyu, et al.
Publicado: (2022)

Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis
por: Mishra, Prachi, et al.
Publicado: (2019)

mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma
por: Liu, Yang, et al.
Publicado: (2020)

IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
por: Shigeta, Keisuke, et al.
Publicado: (2023)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Publicado: (1994)

Correlation of immunohistochemical expression of HIF-1alpha and IDH1 with clinicopathological and therapeutic data of moroccan glioblastoma and survival analysis
por: Sfifou, Fatima, et al.
Publicado: (2021)

Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas()
por: Luks, Tracy L., et al.
Publicado: (2018)

Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma
por: Chen, Song, et al.
Publicado: (2021)

Tenascin turns on the EGFR
por: Jegalian, Karin
Publicado: (2001)

The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015)

Cell biology and mechanopathology of laminopathic cardiomyopathies
por: Miroshnikova, Yekaterina A., et al.
Publicado: (2019)

Mutant IDH1 is required for IDH1 mutated tumor cell growth
por: Jin, Genglin, et al.
Publicado: (2012)

Invasion of Melanoma in Double Knockout Mice Lacking Tenascin‐X and Tenascin‐C
por: Matsumoto, Ken‐ichi, et al.
Publicado: (2002)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer
por: Li, Jiangjiang, et al.
Publicado: (2018)

High expression of PIM2 induces HSC proliferation in myelodysplastic syndromes via the IDH1/HIF1-α signaling pathway
por: Liu, Zhaoyun, et al.
Publicado: (2019)

HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma
por: Zhang, Lili, et al.
Publicado: (2022)

Determinants of Tenascin-C and HIV-1 envelope binding and neutralization
por: Mangan, Riley J., et al.
Publicado: (2019)

Induction of tenascin in healing wounds
Publicado: (1988)

Tenascin Supports Lymphocyte Rolling
por: Clark, Rachael A., et al.
Publicado: (1997)

Advances in tenascin-C biology
por: Midwood, Kim S., et al.
Publicado: (2011)

Tenascin-C and integrins in cancer
por: Yoshida, Toshimichi, et al.
Publicado: (2015)

Transcriptional regulation of tenascin genes
por: Chiovaro, Francesca, et al.
Publicado: (2015)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

Tenascin-X and the pick of destiny
por: Short, Ben
Publicado: (2014)

Tenascin C in Lung Diseases
por: Donovan, Chantal, et al.
Publicado: (2023)

Multilevel regulation of HIF-1 signaling by TTP
por: Fähling, Michael, et al.
Publicado: (2012)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma()()
por: Sun, Chao, et al.
Publicado: (2020)

Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
por: Gupta, Charu, et al.
Publicado: (2020)

Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis
Publicado: (1991)

Early Days of Tenascin-R Research: Two Approaches Discovered and Shed Light on Tenascin-R
por: Rathjen, Fritz G., et al.
Publicado: (2021)

IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
por: DiNardo, Courtney D, et al.
Publicado: (2015)

IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
por: Mondesir, Johanna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dv1ngln17v7fh04nf9i0vttnhm